ESR1 Mutations in Metastatic Breast Cancer
May 16, 2025 • ESR1 Mutated ER HER2 Advanced Breast Cancer Content Hub, HER2+ Breast Cancer Content Hub, Oncology, Women’s Health
Aditya Bardia, MD, MPH, director of translational research integration, UCLA, explains how metastatic estrogen receptor-positive breast cancers can develop ESR1 mutations. Donald McDonnell, PhD, research scientist, Duke University, Durham, North Carolina, discusses how these mutations are different from inherited gene mutations, such as BRCA1/2.
